| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Oregon Bioscience Association Advocate. Cultivate. Educate. Doing all things bio in the Pacific Northwest. Oregon Bioscience Association (@OregonBio) members are involved in cutting edge research and development of innovative health care, agricultural and environmental bio technologies. Our corporate members range from entrepreneurial start ups developing a first product to large multinationals. We also represent the state’s biotech research institutions, service providers to the industry and academic centers of learning. A unified voice for the Oregon bioscience community the Oregon Bio: * Represents the bioscience research to commercialization process * Helps to accelerate the growth of the biosciences industry in all parts of Oregon … Type: | 13 | 0 | 13 | 20 |
 | BioTek Instruments BioTek is worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. Life Science instrumentation and automation and software. Type: | 1 | 0 | 1 | 184 |
 | Aseptix Health Sciences N.V. Aseptix Health Sciences is a global leader in next generation antimicrobials, specializing in novel and patented infection prevention products and technologies for medical, professional and consumer use. Aseptix’ sustainable antimicrobial technologies enable products to safely, effectively and quickly kill contagious pathogens and are used in a wide range of applications, industries and therapeutic areas. The Company markets its products and technologies through a combination of Aseptix branded and third party branded products, and licenses on its portfolio of patented technologies to global industry leaders in their markets. The corporate mission is to become the global alternative for user unsafe and … Type: | 0 | 0 | 0 | 6 |
 | Nemaura Pharma Limited Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the … Type: | 0 | 0 | 0 | 36 |
 | Mithra Transforming Women’s Health Through Innovation Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra … Type: | 1 | 0 | 1 | 524 |
 |  BDD A World Class Drug Delivery Company BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority … Type: | 0 | 0 | 0 | 47 |
 | Celyad Oncology Developing Innovative Cell Therapies Against Cancer Celyad Oncology is a biotechnology company focused on the discovery and development of tecnhlologies and platform for chimeric antigen receptor T cell (CAR T) therapies. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com. Immuno-Oncology, Cancer, Immnotherapy, shRNA multiplex, and CAR T-cells Type: | 0 | 0 | 0 | 44 |
 | VRG Therapeutics Regional leader in preclinical R&D with a world-class protein evolution tech platform for CGT applications Our mission is to cure diseases via targets and MoAs that cannot be reached with traditional approaches. Leveraging our unique platform, we optimize peptides/proteins of natural origin using directed evolution to create cutting-edge CGT products or peptide-based pharmaceuticals. VRGT’s management and staff members were selected based on their international research experience and outstanding pharma industry achievements. Our people have outstanding professional expertise in preclinical/clinical R&D and scientific project management, pharmacology, business development and medical marketing. For years, they have worked in the most prestigious academic … Type: | 1 | 0 | 1 | 26 |
 | Mysthera Therapeutics Multilineage immune modulation. The next chapter in autoimmune diseases. Mysthera is a preclinical stage biotech start-up focused on developing first-in class, oral therapeutics to treat major unmet needs in autoimmune diseases. Our unique approach has potential to transform patient lives in a number of disease settings including glomerulonephritis, rheumatoid arthritis and inflammatory bowel disease. We are first to develop PIM kinase inhibitors as therapeutics for multi-lineage immune cell driven autoimmune diseases. The team are experts in PIM kinase and immunology. Mysthera was founded by Forty51 Ventures in Europe’s pharma/biotech hub, Basel, in Switzerland in early 2023. biotech, kinase inhibitors, autoimmune … Type: | 0 | 0 | 0 | 3 |
 | BioX Diagnostics Innovations in Veterinary Diagnostics Bio-X Diagnostics brings its 25-year experience and know-how in the veterinary diagnostic field to serve your needs and projects. Our products are carefully designed and manufactured in conformity with various standardized testing protocols (laboratory product range) and to meet market demand for rapid detection (point-of-care product range). What sets us apart is our Flexibility, Curiosity and Perseverance, which we apply on a daily basis to support Veterinarians and Professionals in the Animal Health industry. Veterinary Diagnostics, Biotech, Infectious disease, Farm Animals, IVD, ELISA, PCR, and Point of Care Type: | 2 | 0 | 0 | 29 |
 | ANGLE The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. … Type: | 1 | 1 | 0 | 154 |
 | Amarin Corporation Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6 Cardiovascular Type: | 1 | 0 | 1 | 459 |
 | Alimera We See More, TogetherTM Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com . Ophthalmology, Retina, Diabetes, and Pharmaceuticals | 0 | 0 | 0 | 450 |
 | Radiotherapy UK Standing up for vital cancer treatment Radiotherapy UK is the only charity dedicated to improving radiotherapy treatment throughout the UK. We believe that everyone in the country – no matter who they are or where they live – should have access to the best radiotherapy treatment available. We are committed to supporting and promoting radiotherapy professionals across the NHS and private sector. We work with industry partners, professional bodies and cancer charities to raise the profile of radiotherapy and its highly specialised workforce. Radiotherapy, Radiation Therapy, Cancer, Radiotherapy Jobs, Daily Radiotherapy News, Technical Radiotherapy Forum, Radiotherapy Service Documents, and Cancer … Type: | 0 | 0 | 0 | 19 |
 | Lobular Breast Cancer Alliance Inc. LBCA's vision is a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently. As the only organization in the US dedicated to Invasive Lobular Breast Cancer (ILC), LBCA’s mission is to make all who are touched by ILC aware of its unique characteristics and the critical need for more ILC research, to be the go-to source for information on ILC studies, clinical trials and educational tools, to foster relationships among patients, scientists and clinicians to increase dialogue about ILC and patient advocacy, and to fund vital ILC research. lobular breast cancer, invasive lobular carcinoma, ILC, … Type: | 1 | 0 | 1 | 13 |
 | Aromalyse - Chemistry Analysis Expert [Automatic translation follows] Your problem is our technical challenge! Aromalyse is a tailor-made service laboratory in analytical chemistry. Our mission? Investigate and solve increasingly technical problems of our customers thanks to cutting-edge equipment and a team of highly qualified chemists. Our team is constantly pushing the limits of chemistry to allow you to develop products adapted to the expectations of your consumers and to control their quality. Your problem is our technical challenge! Find us on our website: www.aromalyse.com Or contact us: contact@aromalyse.com - 03 80 48 24 80 Analytical skills, Hygiene, safety, environment, Laboratory skills, Tailor-made analyses, Quality (regulations … | 1 | 1 | 0 | 10 |
 | ARCAGY-GINECO [Automatic translation follows] Coordinates international clinical trials in the field of gynecologic and metastatic breast cancers. Arcagy-Gineco is a cooperative group founded in 1993 and specialized in clinical research in the field of women's cancers (gynecologic and metastatic breast cancers). Its objective is to improve the survival and quality of life of patients with gynecologic or metastatic breast cancer by setting up and coordinating therapeutic trials in France and internationally. Arcagy-Gineco brings together medical and scientific expertise in the field of gynecologic oncology and metastatic breast cancer, which gives it a unique capacity to successfully conduct clinical research in the … Type: | 0 | 0 | 0 | 36 |
 | Ripack - Groupe Sefmat La Protection par Excellence In 1922, RIPPES begins its activity by producing flame welding equipment. In 1975 the idea of covering a loaded pallet with a heat shrink cover in order to stabilise the load and offer weather and theft protection, was hatched and rapidly expanded. The RIPPES Company was one of the first to develop a 'gun' connected to a gas supply, which, by dint of its hot flame, shrunk these shrink wrap covers. The rapid expansion of demand for these shrink 'guns' led to the company setting up a new corporate entity in 1981; the SEFMAT company, with … Type: | 1 | 1 | 0 | 15 |
 | HP2 LABORATOIRE To investigate the influence of hypoxia, sleep and exercise on cardiometabolic health trajectories Our goal is to investigate the influence of hypoxia, sleep and exercise on cardiometabolic health trajectories with molecular, pathophysiological and epidemiological approaches. HP2 LABORATOIRE is a research Inserm unit based out of Grenoble Alpes Univeristy and Grenoble Alpes University hospital, France. The future of medicine relies on the ability to assess disease risk at an individual level, understand molecular mechanisms underlying progression of disease and aggregation of comorbidities and early initiation of personalized interventions. To achieve this goal of precision and personalized medicine in obstructive sleep apnea … Type: | 5 | 4 | 2 | 31 |
 | EKIUM COME TO EXPRESS YOUR TALENT THROUGH OUR AMBITIOUS PROJECTS EKIUM continues its development in France and abroad in the fields of industrial and building Engineering and Automation. We are committed as a partner with the leaders of the chemical, pharmaceutical, energy, oil & gas, aeronautics, food processing industry... Today we are 1200 women and men, experts and enthusiasts. Would you like to join our Ekip * (Ekium Identity Project)? charges.recrutement@ekium.eu We offer jobs in our 25 national offices and abroad (Benelux & Mauritius). industrie, énergie, naval, nucléaire, chimie, and pharmaceutique Type: | 35 | 9 | 16 | 1,402 |
 | Advanced Accelerator Applications We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such as neurology, as we continue to unlock the potential of molecular imaging in nuclear medicine. Type: | 4 | 2 | 1 | 861 |
 | ProteoGenix Accelerate your way to the clinic ProteoGenix is a leading life sciences organization which provides services in molecular biology and immunology and in particular polyclonal and monoclonal antibody development, recombinant protein expression and purification, peptide synthesis as well as gene synthesis. ProteoGenix’s commitment to its clients is to ensure the access to comprehensive and integrated solutions to help our customers develop the tools they need to efficiently conduct their biology and research projects in a time effective manner. Beginning with the synthesis of the gene ProteoGenix develops all the materials required for immunoassay services. Proteogenix’s exceptional and functional expertise combined … Type: | 1 | 1 | 0 | 39 |
 | Drugabilis CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is the President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization Type: | 0 | 0 | 0 | 7 |
 | DIVERCHIM CDMO API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. … Type: | 3 | 2 | 3 | 54 |
 | Institut Pasteur The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research with a network of 33 members worldwide. In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its areas of investigation are emerging infectious diseases, antimicrobial resistance, certain … Type: | 48 | 32 | 22 | 4,123 |
 | BIOASTER Disrupting Healthcare - De-risking Innovation - Transforming Technologies BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of … Type: | 20 | 7 | 14 | 122 |
 | Yposkesi, an SK pharmteco company Partnering to bring your cell and gene therapies to life! ***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.*** Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi … Type: | 14 | 4 | 10 | 182 |
 | Wysa Global leader in AI-driven mental health support, NHS (ORCHA) certified, FDA Breakthrough Device Designation. Wysa is an AI-enabled Coach for mental and emotional wellness. Launched in 2016, Wysa provides early intervention via it's AI chatbot, library of evidence-based self-help tools, and messaging-based support from human coaches. Anonymous, empathetic and available 24x7, Wysa covers 11 million lives, and has helped over 6 million people in 95 countries through 500+ million conversations. Wysa is a global leader in digital mental health, rated 93% by ORCHA, the digital health app evaluation agency used by the NHS, with a 100% on clinical assurance; and … Type: | 9 | 0 | 6 | 151 |
 | Apeel Developing science-backed, technology-supported solutions that help improve the produce experience on shelf. Apeel's evolving technology stack is built on an unprecedented understanding of produce quality and shelf life. This has only deepened as the use of data and technology have given partners a powerful way to accurately and efficiently evaluate produce for ripeness, freshness, and other attributes. Apeel is developing science-backed, technology-supported solutions that help improve the produce experience on shelf. Sustainable Technologies, Crops, Food, Agricultural Services, Environment, Organic, and Biotechnology Type: | 4 | 2 | 2 | 276 |
 | NanOlogy Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or … Type: | 0 | 0 | 0 | 8 |
 | Impel Pharmaceuticals Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism Type: | 1 | 1 | 1 | 51 |
 | One Codex Fast and easy to use microbiome analysis with the leading microbial reference database One Codex is the leading bioinformatics platform for microbial genomics, supporting taxonomic and functional analysis of metagenomic (WGS), 16S, and other sequencing data. We specialize in creating robust, scalable, and secure bioinformatics solutions for metagenomics and microbial genomics, with a strong focus on ease of use. Founded in 2014, the One Codex platform counts thousands of users across leading academic institutions, biotechnology companies, and public sector organizations. One Codex is built on top of Amazon Web Services and is the only microbial genomics offering providing HIPAA-level security, … Type: | 0 | 0 | 0 | 10 |
 | Viridian Therapeutics, Inc. Framing the future of autoimmune diseases Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is … Type: | 2 | 1 | 2 | 149 |
 | Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: | 1 | 0 | 1 | 90 |
 | Akrivis Mission-critical air cooling and cleaning with a low carbon footprint. Akrivis solutions cool equipment and deliver cleanroom conditions in modular buildings and cabins. Specialist units delivering exceptional performance, outstanding reliability, and ultra-low energy usage. Type: | 3 | 1 | 2 | 12 |
 |  Mekonos Inc. Building the future of cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed Life Sciences company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in cell & gene therapies and cell line development. Chipset, Gene Therapies, Drug Development, Genetic Diseases, Oncology, Semiconductor, MEMS, Microfluidics, Rare diseases, and Silicon Type: | 2 | 0 | 2 | 25 |
 | Pear Therapeutics The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first … Type: | 13 | 4 | 1 | 36 |
 | Editas Medicine What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One … Type: | 6 | 0 | 1 | 336 |
 | Medical Informatics Corp. Savings Lives Bit By Bit. Medical Informatics Corp. (MIC) is setting a new standard of care founded on improved patient monitoring, real-time predictive analytics, and patient-centered healthcare. We empower every member of the medical team to improve patient care, expedite intervention, reduce risk, and help create financially strong hospitals by enabling more informed, data-driven decisions. Our SickbayTM️ clinical surveillance and analytics platform features a vendor-neutral Time Series Data Engine (TSDE)TM️ and is cleared as a Class II medical device for patient monitoring, analytics, and alarm distribution. Using Sickbay, physicians, researchers and other members of the care team can go beyond … Type: | 6 | 0 | 6 | 89 |
 | Caribou Biosciences Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of off-the-shelf, or allogeneic, cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Next-generation CRISPR genome editing, allogeneic CAR-T cell therapies, oncology, and … Type: | 8 | 1 | 2 | 167 |
 | Sirenas Bringing you a new generation of health products inspired by marine biodiversity Over the last decade and working with experts and local communities, Sirenas has sustainably and ethically built one of the largest and most unique collections of marine organisms and plants from diverse ecosystems and geographies. From the deep sea to coral reefs and estuaries. We’ve run these samples through cutting edge and proprietary chemical extraction and analytics, and tested each one in over 70 in-vitro biological assays relevant to human health. The result is the largest repository of information connecting the unchartered chemistry of marine organisms to applications … Type: | 1 | 1 | 0 | 12 |
 | BIOLIFE4D Build a Heart. Save a Life. Pioneered by accomplished business leaders, guided by world-class biomedical and life science experts, and financed through equity crowdfunding, BIOLIFE4D is driving a movement to transform the treatment of heart disease, the leading cause of death worldwide. Leveraging advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation, this biotech company is committed to optimizing the process and technology around viable human organ replacement, and making it a safe, accessible, commercially viable, and cost-effective reality. Type: | 0 | 0 | 0 | 7 |
 | Torq Labs Torq Smart Clothing: Multi-Sensor Wearable Technology for Athlete Safety and Performance Improvement | Return - To- Play Torq Labs is leading Return to Play and Sports Performance technology with the launch of Torq Smart Clothing; Lightweight, Wireless, Multi-Sensor fitness clothing for athlete safety and performance improvement. Pre-Hab, not Rehab. Our proprietary hardware and motion AI is assisting in return to play research and development to reduce the incidence of crucial joint systems including the knees, hips, ankles, neck, shoulders, and elbows. Full-body analysis, Multi-Sensor Wearable Technology Featured in Foundations the Documentary : https://foundation-thedoc.com/ Founders: Julian Holtzman - CEO Justin Swenson- … Type: | 0 | 0 | 0 | 4 |
 | Freenome Outpacing cancer starts with early detection Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures. A ‘Freenomer’ … Type: | 10 | 3 | 4 | 445 |
 | Kebotix Materials for tomorrow, Today Kebotix is a technology company ushering in the future of new materials discovery. Developing the world’s first self-driving lab for materials discovery powered by AI and robotics, Kebotix is committed to accelerating the exploration, discovery, applications and production of new molecules and materials. Type: | 4 | 1 | 3 | 9 |
 | Ligandal Ligandal is developing precision molecular therapeutics and targeted delivery technologies. Ligandal is a genetic medicine company that uses nanotechnology to develop targeted and personalised therapies. As a regenerative medicine biotechnology company, Ligandal develops ultra-rapid therapeutics and vaccines for outbreaks and pandemics, in addition to its work in immuno-oncology and rare genetic diseases. Our current focus is on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus), as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. Given that increasingly complex disease states require precise and custom-tailored medicine, … Type: | 1 | 1 | 0 | 13 |
 | Reltio Data Unification & Management: Entity Resolution | Multidomain MDM | 360 Data Products At Reltio, we believe data should fuel business success. Our AI-powered data unification and management offerings — Reltio Entity Resolution, Multidomain Master Data Management (MDM), and 360 Data Products—transform siloed data from disparate sources into unified, trusted, and interoperable data. Powered by the Reltio Connected Data Platform, these offerings unify and deliver interoperable data where and when it's needed, empowering data and analytics leaders with unparalleled business responsiveness. Many leading enterprise brands—across multiple industries around the globe—rely on our award-winning data unification and cloud-native MDM capabilities to … Type: | 17 | 0 | 14 | 562 |
 | Solugen Decarbonizing the physical world. At Solugen, we believe planet-scale change starts with the chemistry we use every day. We’re revolutionizing how things are made with the world’s first carbon negative molecule factory: the Bioforge. Harnessing the power of evolved enzymes, plant-based feedstocks, and clean, catalytic reactions, we are making the materials we need to sustain life on Earth—faster, cheaper, and without emissions or waste. green chemistry, oil and gas chemicals, iron sulfide control, hydrogen sulfide control, corrosion inhibitor, scale inhibitor, production chemicals, oilfield chemicals, enzymes, green chemicals, biobased chemicals, and decarbonization Type: | 13 | 1 | 10 | 180 |
 | Nara Logics Synaptic Intelligence for better decisions. Nara Logics uses synaptic intelligence to help companies make better decisions. Our cloud-based platform provides better recommendations — for personalization or decision support — with a brain-inspired approach that connects information for real-time contextual responses. Follow us on Twitter at @naralogics to see what we're up to. personalization, big data, synaptic networks, PaaS, neuroscience, recommendations, artificial intelligence, digital transformation, small data, and ai Type: | 4 | 1 | 0 | 18 |
 | Molecular Plasma Group WE ARE HIRING - Contributing to a better world by building technology for single step, dry surface functionalisation MPG offers a disruptive Key Enabling Technology (KET) that enables the creation of a wide range of advanced surface functionalities. Examples of what can be achieved using our Molecular Plasma Technology include: adhesion promotion, one-step immobilisation of bio-molecules, virucidal coatings, silicone-free release functionalities, tune-able super-hydrophobicity or hydrophilicity, microfluidic channeling and much more. We achieve this by activating a surface and covalently binding the precursor molecules onto the surface using our proprietary Molecular Plasma Process. The outcome is a permanently bonded, custom-designed, nano-metric … Type: | 5 | 1 | 5 | 31 |
 | NFW Nothing but nutrients. NFW is a circularity platform for plastic-free performance materials. NFW follows three Ground Rules in everything we develop: start well, stay clean, end well. While nearly everything in the built world relies on some type of plastic that began as crude oil and that will become plastic pollution, we are establishing a new material reality. We believe all materials should begin and end as nutrients, ready for the next growth cycle—true circularity. Our multi-material platform serves a wide range of industries—from fashion and footwear to automotive and upholstery. NFW technology embeds seamlessly into existing supply chains, enabling … Type: | 15 | 6 | 11 | 210 |
 | Mi Terro® Engineer agricultural waste into high-value, low-cost, and scalable biomaterials to end microplastics and hunger. Mi Terro is a venture-backed advanced material company that engineers agricultural waste into high-quality, low-cost, and scalable biomaterials to end microplastics – this is a first-of-its-kind approach. We are excited to see such a significant leap forward in our ability to manipulate nature’s most diverse and abundant building blocks. Our technologies are patented and are USDA Bio-based Certified. Mi Terro uses a selection of biopolymers and natural fibers with the aim of maximizing the use of agricultural side streams (non-food feedstock) and certified biomasses. While bio-based, … Type: | 10 | 2 | 6 | 13 |
 | Diversigen, Inc. From complexity to clarity in the microbiome Accelerate and transform discovery research and capitalize on the diverse opportunities of the microbiome with Diversigen. Diversigen provides comprehensive fee-for-service microbiome and metagenomics services focused on solutions to improve human, animal, and environmental health. Diversigen is at the forefront of setting industry standards for quality with a microbiome CLIA/CAP accredited, GLP compliant laboratory. Diversigen has extensive experience with highly diverse microbiome sample types and provides full project life cycle consulting services, building on research conducted at Baylor College of Medicine in the Alkek Center for Metagenomics and Microbiome Research. From pre-project consulting, study … Type: | 2 | 1 | 1 | 23 |
 | re.flex - Physical therapy made simple Motion tracking sensors that enable your patients to finish their last stage of the physical rehabilitation at home. Motion tracking sensors that enable your patients to finish their last stage of the physical rehabilitation at home, under your team's supervision. medical device, physiotherapy, telerehabilitation, orthopaedic physiotherapy, physical therapy, remote patient monitoring, physiotherapy device, and physiotherapy wearable Type: | 1 | 0 | 1 | 7 |
 | QUALIPLANTE Your best partner in plant health testing Qualiplante is a French start-up specialized in the development, the production and the commercialisation of innovative molecular diagnostic tools for the detection of plant diseases. Find the best tool for your plant health testing! Qualiplante offers to plant certification laboratories and all actors of agro-food industry, rapid and easy-to-use all-inclusive molecular kits that permit to detect, in a reliable and sensitive way, pathogens on crops. Validated by worldwide scientific experts, they include all the tools to perform a molecular analysis (ready-to-use master mix, positive and negative controls, analysis protocol). Thanks to the new … Type: | 0 | 0 | 0 | 1 |
 | SkinDermic Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. Type: | 0 | 0 | 0 | 5 |
 | ViroScan3D Solutions Personnalisées de Génomique ViroScan3D is a service provider in genomic and micro-genomic located in Lyon. We have ten year experience in genome scale analyses from sample preparation to data analysis. During those years we have developed specific processes dedicated to complex samples (low quality and quantity samples). We propose our services for -Molecular broad spectrum identification of infectious agents, new agents, resistance mutants by whole genome sequencing of viruses and microorganisms (bacteria, yeast, fungi, etc.) -Analysis of complex populations using the metagenome, virome, bacteriome approach to identify the different agents in the population and their proportions -The identification of … Type: | 0 | 0 | 0 | 2 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | Anova-Plus [Automatic translation follows] Our mission: to make our genetic and agronomic experiences available to the agro-industry by creating tools Anova-Plus is an innovative company labeled GENOPOLE, created in 2012. We improve plant health for better animal and human well-being and develop early diagnostic tools to better understand crop enemies and thus better combat them. Innovation in favor of sustainable, responsible and environmentally friendly agriculture is a fundamental point in our company's approaches and projects. Our Flashdiag® and MULTIgene® kits allow precise characterization of pathogens and weeds in order to optimize the technical itineraries of agricultural production. Biotechnology, Plant pathology, Plant … Type: | 2 | 1 | 1 | 4 |
 | BIOMILLENIA Microbiology assays at previously impossible speeds and strain banks with amazing diversity ! Microbiology is what we do. Our unrelenting focus has enabled us to develop unique capabilities in ultra-high-throughput single-cell culture of microorganisms. Businesses in areas as diverse as pharma, agriculture, food, human health and environmental protection have partnered with us to gain powerful competitive advantages from our technology.So could yours. Our proprietary microfluidic platform is capable of : - identifying microbes of interest based on their functional characteristics among millions of candidates - perform a wide range of assays at previously impossible speeds - generate strain banks with … Type: | 0 | 0 | 0 | 5 |
 | SynHelix (now Quantoom Biosciences, a Univercells Company) Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology Type: | 2 | 2 | 1 | 122 |
 | OxiProteomics Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a technology-based start-up committed to promoting the healthy living and healthy aging of human population. We deliver proven science services to dermo-cosmetic and food industries to support marketing claims. We also offer environmental quality bio-monitoring solutions to promote sustainable development. OxiProteomics patented technologies are based on the direct and specific detection of functional high quality proteins vs. oxidatively damaged (carbonylated) in biological samples, with a remarkably specificity and sensitivity. We can detect and quantify for the first time, the quality of thousands proteins … Type: | 2 | 1 | 1 | 12 |
 | Alpioner Therapeutics Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens. Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR). Type: | 18 | 4 | 1 | 3 |
 | Natura Meliss' [Automatic translation follows] A zero-waste and natural bathroom “Mixed, healthy and effective products based on Ayurvedic plants” The idea of Natura Méliss’ was born after a 15-year experience as an engineer in a pharmaceutical Research and Development laboratory. I was not convinced by the cosmetics I found in stores. So I decided to look for solutions. I discovered Ayurvedic medicine a few years ago. Ayurveda, or Ayurvedic Medicine, is a therapeutic system created in India about 5000 years ago. In Sanskrit the word “Ayurveda” is a combination of two words “ayur”, which means “life” and “veda”, which means “science”. Thus … Type: | 1 | 1 | 0 | 1 |
 | CleveXel Pharma Created in 2013, CleveXel Pharma is a pharmaceutical company with an innovative business model based on maximizing the marketing potential of disruptive molecules in exchange for a stake in the partner's equity or for the gradual purchase of a license. LIFE SCIENCES, PHARMACEUTICAL DEVELOPMENT, CLINICAL RESEARCH, and QUALITY / COMPLIANCE | 0 | 0 | 0 | 15 |
 | G.CLIPS biotech ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization … Type: | 12 | 2 | 5 | 6 |
 | MEGA BIOPHARMA [Automatic translation follows] Healing the living with care French player in marine biotechnology, pioneer in the development of Bionacre®, a natural biomaterial extracted from mother-of-pearl. Type: | 1 | 1 | 0 | 19 |
 | AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine Type: | 0 | 0 | 0 | 1 |
 | Syntivia Preclinical and R&D expertise for skin health care Syntivia helps you access the latest innovations in science for your skin research. Our experts in skin biology test and develop new molecules, active ingredients and formulas using the latest tools and techniques in cellular biology, molecular biology, green chemistry, click chemistry and plant extraction. Our scientific expertise, hi-tech equipment and know-how takes into account the latest market tendencies and regulatory requirements of the cosmetics market and pharmaceutical reserach. Skin health care, High-tech imaging equipment, Evaluation of skin drugs and cosmetic ingredients, Skin Biology, Tissue & cell culture, Skin explant, Biotechnology, Human … Type: | 0 | 0 | 0 | 9 |
 | INFYNITY BIOMARKERS SAS Maximizing Immunoassays Performances InfYnity Biomarkers was founded in 2009 in Lyon (France). We are an R&D In-Vitro Diagnostics Company fully dedicated to infectious diseases and immunity. Company Mission: Maximizing Immunoassay Performance i.e. we have the ambition to set new criteria for immunoassays: study the diversity of immune response to provide high-value information instead of the binary response. Our Offer: - High quality, custom-made biomaterial (antigens and antibodies) - RUO Multiplex Immunoassays - Tailored immunobiology services ranging from biomaterial design to biomarker discovery and immunoassay development. Our originality and strength relies on a unique combination of proven skills: Multiplex technology AND … Type: | 0 | 0 | 0 | 7 |
 | IMACTIV-3D Unlock the full potential of your preclinical studies with 3D imaging, image processing and our biological models Imactiv-3D mission is to assess the efficacy of a molecule of interest by using innovative imaging and quantification tools, and by implementing powerful image processing algorithms on relevant 3D models. Imactiv-3D is a fee-for-services company born from the meeting between biology, imaging and image processing experts. By working together, we have developed 3D imaging procedures to explore biological samples and image analysis algorithms to automatize and strengthen characterization and quantification on innovative 3D models. This complementary expertise along with our R&D service allow … Type: | 2 | 0 | 2 | 6 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 2 | 1 | 1 | 12 |
 |  Nosty Making Pharma democratic. Nosty is a decentralized platform where stakeholders in drug development work together to bring new therapeutics to patients faster and more efficiently than ever. The platform enables leading researchers and labs to raise fund among patients and the general public by turning IP and its development into a liquid and easily investable asset. The project is led by a team of serial entrepreneurs and professionals from the pharmaceutical industry, based in US and Europe. Type: | 2 | 2 | 0 | 1 |
 | aKen Medical The Next-generation of personalized and adaptive radiotherapy. αKen Medical is a biotechnology company aiming to develop and bring to market the Next-generation of personalized and adaptive radiotherapy for treating solid cancer tumors. The proposed therapies seek to improve the effectiveness of alpha therapy and reduce its side effects. Radiotherapy, Cancer treatment, Brachytherapy, Targeted therapy, Biotechnology, Medical devices, Alphatherapy, Nanotechnology | 7 | 3 | 2 | 3 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 1 | 1 | 0 | 11 |
 | En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing Type: | 5 | 3 | 3 | 6 |
 | BELAB R&D : Développement de dispositifs d’analyse physiologiques connectés pour la mesure de la sudation en temps réel We are a Start Up of innovators, caring people and believers in a u cause. Within the biotech area, we create state of the art and patented solutions to address an important concern : the measurement and monitoring of crucial physiologic indicators of sweat. The Be-Lab Team, Live better, together. | 4 | 3 | 2 | 14 |
 | IDS Group SAS IDS-Inside; if you want to know the truth IDS Group SAS is a deep tech company with patented technology using isotopes for traceability and marking technologies across industries where source of origin, traceability and authenticity are required. IDS Group specializes in the Research, Development and Production of isotopic Forensic Marking Technologies. Forensic Marking Technologies, Analytical Geochemistry, Food Authenticity, Stable Isotopes, Raw Material Integration, External Forensic Marking Technologies, Geochemistry Big Data, Laser Induced Based Spectroscopy, Mass Spectrometry, Biofuel traceability, and Traceability Type: | 0 | 0 | 0 | 3 |
 | EphyX Neuroscience CNS Electrophysiology experts at your service EphyX Neuroscience is a Contract Research Organization (CRO) with a focus on in vitro electrophysiology for preclinical research and drug discovery in the Central Nervous System (CNS) field. Our mission is to empower our clients with the knowledge they need to make informed decisions about their compound selection, by providing comprehensive insights into the mechanisms of action. Our team comprises highly skilled experts who specialize in performing in vitro electrophysiological recordings on a diversity of highly physiological preparations, including both rodent and human models. Our experience and technical expertise ensures that the data we … Type: | 0 | 0 | 0 | 2 |
 | Altevax Biotech Altevax is developing a disruptive immunotherapy technology against cancer Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and … Type: | 11 | 3 | 5 | 6 |
 | MINAPATH Développement [Automatic translation follows] A healthy life is a life without dust. MINAPATH is based on the research of exposures to mineral particles. These exposures can be by air, digestive tract, skin-mucous contact or prosthesis implantation... It can be an inflammatory, fibrotic, degenerative or cancerous disease. health and disease Type: | 0 | 0 | 0 | 2 |
 | AmyPore New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and other proteinopathies AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay … Type: | 1 | 1 | 0 | 1 |
 | Suricog SuriCog was founded in mid-2013 by Marc Massonneau, serial entrepreneur in medical devices & services, and some other passionate people, to develop new generation of gaze-based diagnostic tools in order to improve patient pathways in neurology and psychiatry. In 2016, we acquired a company which developed a 10M€ program for best-in-class eye-movement acquisition and analysis solutions in several key neurological diseases Drawing from over a quasi-decade of eye studies, algorithm development, optoelectronics design, high-end software, and clinical trials and applications, we have advanced our technology for integration in a data-driven complete solution, as the fundamental for medical oriented eye-tracking. The … Type: | 2 | 3 | 0 | 23 |
 | E-PHY-SCIENCE E-PHY-SCIENCE is a service company specialized in In-vivo and In-vitro electrophysiological assays. If you are currently developing a program in CNS disorder, we can help you increase your chances of success. By gathering on the same platform In-Vivo and In-Vitro electrophysiological assays, the E-PHY-SCIENCE team is able to offer you a complete range of studies. These assays can reveal specific abnormalities in many genetic models of human brain disease, as well as the effect of new molecules on normal brain functions. These types of experiment provide insights for new therapies as well as understandings of brain diseases mechanisms. We cover … Type: | 1 | 0 | 0 | 10 |
 | ProGeLife [Automatic translation follows] Innovative research solutions for rare diseases Development of drugs for the treatment of rare genetic diseases with premature or accelerated aging Type: | 0 | 0 | 0 | 9 |
 | ATLANTHERA Bone targeted delivery concept Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network Our concept: Bone-targeted delivery of anti-cancer drug www.atlanthera.com Watch our concept in video > https://youtu.be/m3BBWguO6hs Durg discovery, Bone-targeted drug delivery, Bone cancer, and Bone metastases Type: | 2 | 1 | 2 | 11 |
 | GOLIVER THERAPEUTICS Repair the liver without graft GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation. GOLIVER THERAPEUTICS aims to become a Worldwide leader inregenerative medicine in providing the first cell-based therapy product for life-threatening liver failures. Type: | 5 | 1 | 5 | 32 |
 | OCRvet Your partner for comparative medicine studies Oncovet Clinical Research (O.C.R.) is an innovative Contract Research Organization specialized in the conception and management of clinical trials on Dogs & Cats models with naturally occurring pathologies for efficacy assessment of drug candidates for Human Health. O.C.R. innovative offer is at the forefront of ethics of research involving animals since Dogs & Cats included in clinical trials benefit from new therapies developed for Human. O.C.R. main therapeutic fields are Oncology, Inflammation, Cardiology & Neurology. O.C.R. proposes to support Pharma & Biotech in furthering their drug development programs (in preclinical & clinical phases) by … Type: | 3 | 1 | 1 | 21 |
 | METAFORA biosystems AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, and research Type: | 17 | 2 | 12 | 34 |
 | Olea Medical - Improved Diagnosis for Life Improved Diagnosis for Life Olea Medical, a provider of advanced MR and CT perfusion imaging post-processing, designs medical imaging applications improving diagnostic processes. Olea Medical was incorporated in 2008, but its history began in 1998, when its founder, then a young medical school student, decided to transition to computer engineering. A trick of life plunged him into the world of medical research to design software dedicated to the processing of medical images for hyper acute stroke – the ancestor of PerfScape and NeuroScape. After a ten-year career in military informatics, the idea of Olea Medical emerged with three other engineers, … Type: | 8 | 0 | 1 | 126 |
 | LiMM Therapeutics LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells. LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes - to preserve health and treat inflammatory, infectious and metabolic diseases. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients. Type: | 0 | 0 | 0 | 5 |
 | EG 427 Pinpoint Gene Therapy At EG427 our unique, non-replicative Herpes Simplex Virus type 1 (HSV-1) based vector platform delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes to address prevalent diseases in neurology. Our lead asset EG110A, for the treatment of neurogenic bladder dysfunction, has received IND clearance in June 2024 from the US FDA. Our revolutionary approach to the treatment of this disease aims at providing patients with a comprehensive, long-term solution to their bladder management, through a highly selective molecular biology approach overcoming the drawbacks of current standard of care. Our HQ and labs are in … Type: | 2 | 2 | 0 | 23 |
 | Rarecells Detect and defeat cancer from its start through a simple blood draw. Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique … Type: | 1 | 1 | 0 | 20 |
 | Scipio bioscience Single-cell sequencing on every benchtop At Scipio bioscience we are passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio propels the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provides all researchers with Empowered Autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for the highest-quality results and true biological information. We will be glad … Type: | 2 | 1 | 1 | 28 |
 | Innoskel Developing novel therapies for rare bone diseases Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their … Type: | 7 | 6 | 0 | 11 |
 | Invectys Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product. Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens. oncology, immunotherapy, … | 1 | 1 | 0 | 23 |
 | Evora Biosciences First-in-class immunomodulatory peptides. Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need. immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation Type: | 4 | 3 | 1 | 7 |
 | Orphalan At Orphalan we strive to develop rare disease treatments to improve patients lives. Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. | 3 | 2 | 2 | 110 |
 | Egle Therapeutics Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones. Type: | 1 | 1 | 0 | 37 |
 | Step Pharma Developing selective inhibitors of CTPS1 for patients with cancer and auto-immune diseases Step Pharma is the world leader in the discovery and development of inhibitors of CTPS1 (cytidine triphosphate synthase 1) for the treatment of cancer and autoimmune diseases. Step Pharma’s lead program STP938 is a potent, selective, oral inhibitor of CTPS1 with demonstrated potent anti-tumor activity in models of leukemia and lymphoma. STP938 will enter clinical development in 2022 for the treatment of relapsed and refractory T-cell and B-cell lymphoma. Type: | 1 | 0 | 0 | 16 |
NGO, Think-tanks, Ed, & Culture